Literature DB >> 7901154

Reduced levels of CD2+ cells and T-cell subsets in patients with sickle cell anaemia.

S A Kaaba1, S A al-Harbi.   

Abstract

Investigation of B lymphocytes and T-lymphocyte subsets in patients with homozygous sickle cell disease (SCD) who were not in crisis and who did not demonstrate infectious complications showed these cell populations to be abnormal. The proportion of total T cells (CD2+) was significantly reduced (P = 0.002) when compared with controls. B cells (CD19+) were significantly elevated in sicklers (P = 0.029). Helper/inducer (CD4+) and suppressor/cytotoxic (CD8+) cells were significantly reduced (P = 0.019 and P = 0.0001, respectively). The average ratio of T cells/B cells in SCD patients was 3.7:1, while controls showed a ratio of 7.2:1. Since patients with SCD are abnormally susceptible to severe infections, we discussed the implications of low levels of CD4+ and CD8+ cells and the consequent cytokine imbalance in SCD patients which may lead to impairment of immunity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7901154     DOI: 10.1016/0165-2478(93)90135-o

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  9 in total

1.  Immune regulation in chronically transfused allo-antibody responder and nonresponder patients with sickle cell disease and β-thalassemia major.

Authors:  Weili Bao; Hui Zhong; Xiaojuan Li; Margaret T Lee; Joseph Schwartz; Sujit Sheth; Karina Yazdanbakhsh
Journal:  Am J Hematol       Date:  2011-09-26       Impact factor: 10.047

Review 2.  Alteration of lymphocyte phenotype and function in sickle cell anemia: Implications for vaccine responses.

Authors:  Emmanuel Balandya; Teri Reynolds; Stephen Obaro; Julie Makani
Journal:  Am J Hematol       Date:  2016-07-14       Impact factor: 10.047

3.  Allogeneic haematopoietic stem cell transplantation resets T- and B-cell compartments in sickle cell disease patients.

Authors:  Luciana Ribeiro Jarduli-Maciel; Júlia Teixeira Cottas de Azevedo; Emmanuel Clave; Thalita Cristina de Mello Costa; Lucas Coelho Marlière Arruda; Isabelle Fournier; Patrícia Vianna Bonini Palma; Keli Cristina Lima; Juliana Bernardes Elias; Ana Beatriz Pl Stracieri; Fabiano Pieroni; Renato Cunha; Luiz Guilherme Darrigo-Júnior; Carlos Eduardo Settani Grecco; Dimas Tadeu Covas; Ana Cristina Silva-Pinto; Gil Cunha De Santis; Belinda Pinto Simões; Maria Carolina Oliveira; Antoine Toubert; Kelen Cristina Ribeiro Malmegrim
Journal:  Clin Transl Immunology       Date:  2022-04-23

4.  In-Depth Immunological Typization of Children with Sickle Cell Disease: A Preliminary Insight into Its Plausible Correlation with Clinical Course and Hydroxyurea Therapy.

Authors:  Giulia Giulietti; Daniele Zama; Francesca Conti; Mattia Moratti; Maria Teresa Presutti; Tamara Belotti; Maria Elena Cantarini; Elena Facchini; Mirna Bassi; Paola Selva; Elisabetta Magrini; Marcello Lanari; Andrea Pession
Journal:  J Clin Med       Date:  2022-05-27       Impact factor: 4.964

5.  TIGIT-positive circulating follicular helper T cells display robust B-cell help functions: potential role in sickle cell alloimmunization.

Authors:  Emmanuelle Godefroy; Hui Zhong; Petra Pham; David Friedman; Karina Yazdanbakhsh
Journal:  Haematologica       Date:  2015-08-06       Impact factor: 9.941

6.  Splenic morphological changes are accompanied by altered baseline immunity in a mouse model of sickle-cell disease.

Authors:  Steven M Szczepanek; Jeffrey T McNamara; Eric R Secor; Prabitha Natarajan; Linda A Guernsey; Lauren A Miller; Enrique Ballesteros; Evan Jellison; Roger S Thrall; Biree Andemariam
Journal:  Am J Pathol       Date:  2012-09-19       Impact factor: 4.307

7.  CD4+ T Lymphocytes count in sickle cell anaemia patients attending a tertiary hospital.

Authors:  Omotola Toyin Ojo; Wuraola Adebola Shokunbi
Journal:  Niger Med J       Date:  2014-05

8.  Implications of COVID-19 infections in sickle cell disease.

Authors:  Nitin Ashok John; Jyoti Elgiva John
Journal:  Pan Afr Med J       Date:  2020-06-09

9.  Sickle Cell Anemia Patients Display an Intricate Cellular and Serum Biomarker Network Highlighted by TCD4+CD69+ Lymphocytes, IL-17/MIP-1β, IL-12/VEGF, and IL-10/IP-10 Axis.

Authors:  Nadja Pinto Garcia; Alexander Leonardo S Júnior; Geyse Adriana S Soares; Thainá Cristina C Costa; Alicia Patrine C Dos Santos; Allyson Guimarães Costa; Andréa Monteiro Tarragô; Rejane Nina Martins; Flávia do Carmo Leão Pontes; Emerson Garcia de Almeida; Erich Vinícius de Paula; Olindo Assis Martins-Filho; Adriana Malheiro
Journal:  J Immunol Res       Date:  2020-01-08       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.